These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
419 related items for PubMed ID: 24820742
1. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices. Versaci F, Nardi S, Trivisonno A, Olivieri C, Caranci F, Prati F. Int J Cardiol; 2014 Aug 01; 175(2):370-1. PubMed ID: 24820742 [No Abstract] [Full Text] [Related]
2. "In-stent" renal denervation for the treatment of severe resistant hypertension. Marchese A, Secco GG, Chierchia S, Iorio E, Castriota F. Int J Cardiol; 2014 May 15; 173(3):e25-6. PubMed ID: 24713456 [No Abstract] [Full Text] [Related]
3. [Catheter-based renal denervation: a new method for resistant hypertension. Initial experiences of the procedure shows significant decrease in blood pressure]. Rundqvist B, Völz S, Manhem K, Herlitz H, Haraldsson I, Andersson B. Lakartidningen; 2014 May 15; 110(3):86-8. PubMed ID: 23424985 [No Abstract] [Full Text] [Related]
4. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence. Hiremath S, Froeschl M, Ruzicka M. Curr Opin Cardiol; 2014 Jul 15; 29(4):336-43. PubMed ID: 24859619 [Abstract] [Full Text] [Related]
5. Renal denervation for hypertension. Eleid MF, Schwartz GL, Gulati R. Curr Probl Cardiol; 2014 Feb 15; 39(2):35-51. PubMed ID: 24412003 [Abstract] [Full Text] [Related]
6. Renal Denervation to Modify Hypertension and the Heart Failure State. Zhong M, Kim LK, Swaminathan RV, Feldman DN. Interv Cardiol Clin; 2017 Jul 15; 6(3):453-464. PubMed ID: 28600097 [Abstract] [Full Text] [Related]
7. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Hypertension; 2011 Oct 15; 58(4):559-65. PubMed ID: 21844482 [Abstract] [Full Text] [Related]
8. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au. Hypertension; 2011 May 15; 57(5):911-7. PubMed ID: 21403086 [Abstract] [Full Text] [Related]
19. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients: more questions than answers. Dimitriadis K, Tsioufis C, Tousoulis D. Int J Cardiol; 2014 Oct 20; 176(3):1382. PubMed ID: 25147074 [No Abstract] [Full Text] [Related]